Skip to main content
. 2023 Jan 31;30(4):173–185. doi: 10.32604/or.2022.027262

Table 4. Comorbidity prevalence as percentage of lung cancer incident cases in 2008–2018 by sex and age group.

Men Women 18–35 35–50 50–65 65–80 80+
Comorbidity
Myocardial infarction 8.6 3.7 0.0 1.6 4.1 7.5 8.3
CHF 19.1 13.5 2.2 4.4 9.5 18.4 28.9
PVD 21.4 15.5 7.1 10.8 16.3 21.2 17.4
CEVD 10.5 8.0 2.2 2.7 6.4 10.7 13.1
Dementia 3.2 3.1 0.0 0.0 0.6 3.0 10.1
COPD 38.7 34.4 16.9 24.6 36.2 39.8 30.9
Rheumatoid disease 1.4 3.0 0.6 1.2 2.1 2.3 2.0
Peptic ulcer 3.0 2.3 1.6 1.6 2.4 2.9 3.1
Mild liver disease 5.3 4.6 1.6 5.1 5.9 4.9 3.2
Diab. without chron. compl. 20.9 13.4 3.3 4.8 13.1 20.6 19.4
Diab. with chron. compl. 5.7 2.8 0.0 0.6 2.5 5.4 6.1
Hemiplegia or paraplegia 5.5 5.1 2.2 3.8 5.6 5.4 4.9
Renal disease 17.2 11.7 2.2 3.0 6.8 16.7 28.1
Moderate or severe liver dis. 0.9 0.4 0.0 0.6 0.8 0.7 0.4
AIDS 0.1 0.0 0.5 0.4 0.2 0.0 0.0
Number of comorbidities
0 26.2 35.8 68.3 54.8 36.4 26.6 24.8
1 or 2 50.9 50.0 30.6 41.5 52.2 51.1 47.7
3 or 4 18.8 12.0 1.1 3.2 10.0 18.2 22.3
5 or more 4.2 2.2 0.0 0.4 1.5 4.0 5.2

Note: Comorbidities are classified with the categories listed in the Charlson Comorbidity Index (CCI). COPD stands for chronic obstructive pulmonary disease, PVD for peripheral vascular disease, CHF for congestive heart failure and CEVD for cerebrovascular disease.